臺灣血液透析實作指引 (TW HD IG)
0.0.2 - ci-build Taiwan, Province of China flag

臺灣血液透析實作指引 (TW HD IG) - Local Development build (v0.0.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Capability Statement
... 3 Code Systems
... 4 Concept Maps
... 5 Downloads
... 6 Examples
... 7 Extensions
... 8 Logical Models
... 9 Profiles
... 10 Search Params Operations
... 11 Value Sets
... 12 Artifacts Summary
.... 12.1 血液透析交換伺服器能力聲明 (HD Server Capability Statement)
.... 12.2 透析病例交換 (Hemodialysis Case Exchange)
.... 12.3 一般狀況評估 (HD General Status)
.... 12.4 原發腎臟疾病 (HD Primary Renal Disease)
.... 12.5 合併症 (HD Comorbidity)
.... 12.6 生活活動評估 (HD Functional Status)
.... 12.7 血液透析住出院 (HD Encounter)
.... 12.8 血液透析文件 Bundle (HD Document Bundle)
.... 12.9 血液透析檢驗 (HD Laboratory Observation)
.... 12.10 血液透析治療紀錄 (Hemodialysis Session)
.... 12.11 血液透析病患 (HD Patient)
.... 12.12 血液透析病歷文件 (HD Composition)
.... 12.13 血液透析處方 (Hemodialysis Prescription)
.... 12.14 血管通路處置 (Vascular Access Procedure)
.... 12.15 血管通路血流量 (HD Access Flow)
.... 12.16 血管通路裝置 (Vascular Access Device)
.... 12.17 透析前後血壓 (HD Blood Pressure)
.... 12.18 透析器 (Dialyzer)
.... 12.19 透析用藥 (HD Medication Statement)
.... 12.20 透析相關感染 (Dialysis Infection)
.... 12.21 透析體重 (HD Body Weight)
.... 12.22 EPO 劑量 (EPO Dose)
.... 12.23 EPO 種類 (EPO Type)
.... 12.24 感染發生原因 (Infection Cause)
.... 12.25 感染結果 (Infection Outcome)
.... 12.26 感染菌種 (Infection Organism)
.... 12.27 抗凝劑 (Anticoagulant)
.... 12.28 抗凝劑初劑量 (Anticoagulant Initial Dose)
.... 12.29 抗凝劑維持劑量 (Anticoagulant Maintenance Dose)
.... 12.30 教育程度 (Education Level)
.... 12.31 是否使用 IV 鐵劑 (IV Iron Used)
.... 12.32 是否具福保身分 (Social Welfare Insurance Status)
.... 12.33 是否為原住民 (Indigenous Status)
.... 12.34 本院開始治療日期 (First Dialysis Date at This Facility)
.... 12.35 每次透析時間 (Duration Per Session)
.... 12.36 每週次數 (Sessions Per Week)
.... 12.37 照護場域 (Care Setting)
.... 12.38 病患類別 (Patient Category)
.... 12.39 血液流速 (Blood Flow Rate)
.... 12.40 血管通路型態 (Vascular Access Type)
.... 12.41 血管重建方式 (Access Rebuild Method)
.... 12.42 輸血量 (Transfusion Volume)
.... 12.43 透析代號 (Dialysis ID)
.... 12.44 透析器表面積 (Dialyzer Surface Area)
.... 12.45 透析方式 (Dialysis Modality)
.... 12.46 透析時間點 (Dialysis Timing)
.... 12.47 透析液流速 (Dialysate Flow Rate)
.... 12.48 透析液鈣離子濃度 (Dialysate Calcium)
.... 12.49 透析液鉀離子濃度 (Dialysate Potassium)
.... 12.50 透析液鹼基 (Dialysate Base)
.... 12.51 透析狀態 (Dialysis Status)
.... 12.52 通路側別 (Access Side)
.... 12.53 通路失敗原因 (Access Failure Reason)
.... 12.54 重大傷病卡號 (Catastrophic Illness Card No.)
.... 12.55 首次治療日期 (First Dialysis Date)
.... 12.56 ABO 血型 值集 (abo-blood-group-vs)
.... 12.57 EPO 種類 ATC (Erythropoiesis-Stimulating Agent)
.... 12.58 EPO 種類 值集 (epo-type-vs)
.... 12.59 一般狀況評估 值集 (general-status-vs)
.... 12.60 住院原因大類 值集 (admission-reason-major-vs)
.... 12.61 住院原因細類 值集 (admission-reason-vs)
.... 12.62 其他系統性疾病 值集 (systemic-disease-vs)
.... 12.63 動靜脈廔管位置 值集 (fistula-location-vs)
.... 12.64 原發病大類 值集 (primary-renal-disease-major-vs)
.... 12.65 原發病細類 值集 (primary-renal-disease-vs)
.... 12.66 合併症 值集 (comorbidity-vs)
.... 12.67 導管置入位置 值集 (catheter-location-vs)
.... 12.68 尿毒症狀 值集 (uremic-symptom-vs)
.... 12.69 感染發生原因 值集 (infection-cause-vs)
.... 12.70 感染種類 值集 (infection-type-vs)
.... 12.71 感染結果 值集 (infection-outcome-vs)
.... 12.72 感染菌種 SNOMED CT (Organism)
.... 12.73 感染菌種 值集 (infection-organism-vs)
.... 12.74 抗凝劑 ATC (Anticoagulant)
.... 12.75 抗凝劑 值集 (anticoagulant-vs)
.... 12.76 教育程度 v3 (Education Level)
.... 12.77 教育程度 值集 (education-level-vs)
.... 12.78 照護場域 ActCode (Care Setting)
.... 12.79 物質 SNOMED CT (Substance)
.... 12.80 生活活動評估 值集 (functional-status-vs)
.... 12.81 病患類別 值集 (patient-category-vs)
.... 12.82 病毒標記檢驗結果 值集 (viral-marker-result-vs)
.... 12.83 糖尿病型式 值集 (dm-type-vs)
.... 12.84 緊急透析原因 值集 (emergency-dialysis-reason-vs)
.... 12.85 職業 值集 (occupation-vs)
.... 12.86 處置 SNOMED CT (Procedure)
.... 12.87 血管通路型態 SNOMED CT (Vascular Access Type)
.... 12.88 血管通路型態 值集 (hd-vascular-access-type-vs)
.... 12.89 血管通路失敗原因 值集 (access-failure-reason-vs)
.... 12.90 血管通路左右 值集 (access-side-vs)
.... 12.91 血管重建方式 值集 (access-rebuild-method-vs)
.... 12.92 透析器型號對應 (Dialyzer Model) 值集 (dialyzer-model-vs)
.... 12.93 透析方式 SNOMED CT (Dialysis Modality)
.... 12.94 透析方式 值集 (dialysis-modality-vs)
.... 12.95 透析時間點 值集 (hd-dialysis-timing-vs)
.... 12.96 透析液鹼基 值集 (dialysate-base-vs)
.... 12.97 透析照護場域 值集 (hd-care-setting-vs)
.... 12.98 透析狀態 SNOMED CT (Dialysis Status)
.... 12.99 透析狀態 值集 (dialysis-status-vs)
.... 12.100 透析適應症種類 值集 (dialysis-indication-vs)
.... 12.101 透析體重量測 LOINC (HD Body Weight)
.... 12.102 通路側別 SNOMED CT (Access Side)
.... 12.103 連絡人關係 值集 (contact-relationship-vs)
.... 12.104 鐵劑給藥途徑 值集 (iron-route-vs)
.... 12.105 ABO 血型 (abo-blood-group)
.... 12.106 EPO 種類 (epo-type)
.... 12.107 一般狀況評估 (general-status)
.... 12.108 住院原因大類 (admission-reason-major)
.... 12.109 住院原因細類 (admission-reason)
.... 12.110 其他系統性疾病 (systemic-disease)
.... 12.111 動靜脈廔管位置 (fistula-location)
.... 12.112 原發病大類 (primary-renal-disease-major)
.... 12.113 原發病細類 (primary-renal-disease)
.... 12.114 合併症 (comorbidity)
.... 12.115 導管置入位置 (catheter-location)
.... 12.116 尿毒症狀 (uremic-symptom)
.... 12.117 感染發生原因 (infection-cause)
.... 12.118 感染種類 (infection-type)
.... 12.119 感染結果 (infection-outcome)
.... 12.120 感染菌種 (infection-organism)
.... 12.121 抗凝劑 (anticoagulant)
.... 12.122 教育程度 (education-level)
.... 12.123 生活活動評估 (functional-status)
.... 12.124 病患類別 (patient-category)
.... 12.125 病毒標記檢驗結果 (viral-marker-result)
.... 12.126 糖尿病型式 (dm-type)
.... 12.127 緊急透析原因 (emergency-dialysis-reason)
.... 12.128 職業 (occupation)
.... 12.129 血管通路型態 (Vascular Access Type)
.... 12.130 血管通路失敗原因 (access-failure-reason)
.... 12.131 血管通路左右 (access-side)
.... 12.132 血管重建方式 (access-rebuild-method)
.... 12.133 透析器型號對應 (Dialyzer Model) (dialyzer-model)
.... 12.134 透析方式 (dialysis-modality)
.... 12.135 透析時間點 (HD Dialysis Timing)
.... 12.136 透析液鹼基 (dialysate-base)
.... 12.137 透析照護場域 (HD Care Setting)
.... 12.138 透析狀態 (dialysis-status)
.... 12.139 透析適應症種類 (dialysis-indication)
.... 12.140 連絡人關係 (contact-relationship)
.... 12.141 鐵劑給藥途徑 (iron-route)
.... 12.142 EPO 種類對照表 (KiDiT → WHO ATC)
.... 12.143 抗凝劑對照表 (KiDiT → WHO ATC / SNOMED CT)
.... 12.144 教育程度對照表 (KiDiT → HL7 v3 EducationLevel)
.... 12.145 照護場域對照表 (KiDiT → HL7 v3 ActCode)
.... 12.146 血管通路型態對照表 (本地 → SNOMED CT)
.... 12.147 透析方式對照表 (KiDiT → SNOMED CT)
.... 12.148 透析狀態對照表 (KiDiT → SNOMED CT)
.... 12.149 通路側別對照表 (KiDiT → SNOMED CT)
.... 12.150 範例：住院（血管通路功能不良）
.... 12.151 範例：原發腎臟疾病（糖尿病腎病變）
.... 12.152 範例：導管出口處感染
.... 12.153 範例：檢驗 - 血色素 (Hb)
.... 12.154 範例：理想乾體重
.... 12.155 範例：生活活動評估
.... 12.156 範例：自體動靜脈廔管建立
.... 12.157 範例：血液透析文件 Bundle
.... 12.158 範例：血液透析治療紀錄
.... 12.159 範例：血液透析病患 王小明
.... 12.160 範例：血液透析病歷文件 (Composition)
.... 12.161 範例：血液透析處方
.... 12.162 範例：透析器 Asahi Rexeed-15L
.... 12.163 範例：透析院所